These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 448996)

  • 21. [Use of Progestasert in the treatment of function dysmenorrhea].
    Casella S
    Minerva Ginecol; 1977; 29(7-8):607-10. PubMed ID: 927738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of U-coil progesterone releasing device versus inert U-coil IUD.
    Serour GI; Hamza A; El Sheikha Z; Hefnawi FI
    Popul Sci; 1982; (3):121-35. PubMed ID: 12266213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea.
    Ozgoli G; Goli M; Moattar F
    J Altern Complement Med; 2009 Feb; 15(2):129-32. PubMed ID: 19216660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial.
    Nor Azlin MI; Maryasalwati I; Norzilawati MN; Mahdy ZA; Jamil MA; Zainul Rashid MR
    J Obstet Gynaecol; 2008 May; 28(4):424-6. PubMed ID: 18604680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea.
    Roy S
    Obstet Gynecol; 1983 May; 61(5):628-32. PubMed ID: 6835617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial.
    Shirvani MA; Motahari-Tabari N; Alipour A
    Arch Gynecol Obstet; 2015 Jun; 291(6):1277-81. PubMed ID: 25399316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of primary dysmenorrhea with mefenamic acid.
    Kintis GA; Coutifaris B
    Int J Gynaecol Obstet; 1980; 18(3):172-5. PubMed ID: 6109648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wider opportunities for IUD insertion.
    Cole LP; Potts DM
    IPPF Med Bull; 1983 Feb; 17(1):2-3. PubMed ID: 12264751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between two IUDs: Progestasert and CuT 200.
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effect of honey and mefenamic acid on the severity of pain in women with primary dysmenorrhea.
    Amiri Farahani ËL; Hasanpoor-Azghdy SB; Kasraei H; Heidari T
    Arch Gynecol Obstet; 2017 Aug; 296(2):277-283. PubMed ID: 28623433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of dysmenorrhea.
    Budoff PW
    Am J Obstet Gynecol; 1977 Sep; 129(2):232. PubMed ID: 331958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
    Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L
    Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations.
    Haynes PJ; Flint AP; Hodgson H; Anderson AB; Dray F; Turnbull AC
    Int J Gynaecol Obstet; 1980; 17(6):567-72. PubMed ID: 6106574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The first year of clinical experience with concurrent post abortal insertion of copper "T" 200.
    Rajan R; Usha L; Venkitakrishnan S
    J Obstet Gynaecol India; 1979 Apr; 29(2):248-52. PubMed ID: 12335887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nimesulide in the treatment of primary dysmenorrhea. Comparative clinical evaluation with mefenamic acid and fentiazac].
    López Rosales C; Cisneros Lugo JH; Romo Enciso LJ; García Sandoval MG
    Ginecol Obstet Mex; 1989 Jul; 57():196-201. PubMed ID: 2486951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations.
    Dawood MY
    Drugs; 1981 Jul; 22(1):42-56. PubMed ID: 6790261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hypermenorrhea with mefenamic acid in women using IUDs.
    Pedron N; Lozano M; Aznar R
    Contracept Deliv Syst; 1982 Apr; 3(2):135-9. PubMed ID: 12338167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of mefenamic acid in patients with a complaint of menorrhagia.
    Fraser IS; Pearse C; Shearman RP; Elliott PM; McIlveen J; Markham R
    Obstet Gynecol; 1981 Nov; 58(5):543-51. PubMed ID: 7029369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.